A detailed history of City Center Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, City Center Advisors, LLC holds 6,597 shares of GILD stock, worth $610,684. This represents 0.61% of its overall portfolio holdings.

Number of Shares
6,597
Previous 7,776 15.16%
Holding current value
$610,684
Previous $570 Million 2.9%
% of portfolio
0.61%
Previous 0.67%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$66.59 - $83.99 $78,509 - $99,024
-1,179 Reduced 15.16%
6,597 $553 Million
Q1 2024

Jul 23, 2024

BUY
$71.58 - $87.29 $556,606 - $678,767
7,776 New
7,776 $570 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track City Center Advisors, LLC Portfolio

Follow City Center Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City Center Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on City Center Advisors, LLC with notifications on news.